Schedule 13G ownership disclosure

Acer Therapeutics Inc.

Security class unavailable · CUSIP: 00444P108

Event date: 2018-09-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
536,377
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-18-009610
Form type
SC 13G
Filer
Acer Therapeutics Inc.
CIK
CIK 1069308
Filed
Sep 17, 2018
Reporting period
Sep 07, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub